Apogee Therapeutics, Inc. APGE Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Apogee Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:MarketableSecuritiesCurrent.
The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about Apogee Therapeutics, Inc.'s short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Apogee Therapeutics, Inc.'s short-term investments?
- Apogee Therapeutics, Inc. (APGE) reported short-term investments of $608.09M in Q1 2026.
- How has Apogee Therapeutics, Inc.'s short-term investments changed year-over-year?
- Apogee Therapeutics, Inc.'s short-term investments increased by 49.6% year-over-year, from $406.41M to $608.09M.
- What is the long-term trend for Apogee Therapeutics, Inc.'s short-term investments?
- Over 2 years (2023 to 2025), Apogee Therapeutics, Inc.'s short-term investments has grown at a 47.0% compound annual growth rate (CAGR), from $277.14M to $598.64M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.